Ownership history in Lipe & Dalton · 41 quarters on record
This page tracks every 13F SEC filing in which Lipe & Dalton reported a position in Abbvie Inc (ABBV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 19,205 | -5,180 | -21.2% | 2.17% | $4.4M | $226.67 |
| 2025 Q2 | REDUCED | 24,385 | -450 | -1.8% | 2.45% | $4.5M | $181.25 |
| 2025 Q1 | REDUCED | 24,835 | -560 | -2.2% | 2.91% | $5.2M | $202.72 |
| 2024 Q4 | REDUCED | 25,395 | -90 | -0.4% | 2.39% | $4.5M | $170.33 |
As of 2025 Q4 — sorted by position size